Virtu KCG Holdings’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Virtu KCG Holdings’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$147K	Buy	+1,029	New	+$159K	﹤0.01%	2306
2017 Q1	–	Sell	-3,430	Closed	-$276K	–	3999
2016 Q4	$276K	Buy	3,430 +2,902	+550%	+$230K	0.01%	2204
2016 Q3	$40K	Buy	+528	New	+$42.3K	﹤0.01%	2827
2015 Q4	–	Sell	-1,035	Closed	-$154K	–	4106
2015 Q3	$154K	Buy	+1,035	New	+$760K	﹤0.01%	2682

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's TTPH Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2017: 1,029 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #2306 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in TTPH as recently as Q4 2016.

Virtu KCG Holdings first reported a position in TTPH in Q3 2015 and has held it in 4 quarters since. The position peaked at $276K in Q4 2016. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2017.

Virtu KCG Holdings held 1,029 shares of Tetraphase Pharmaceuticals, Inc. worth $147K as of Q2 2017.
Tetraphase Pharmaceuticals, Inc. was a new Virtu KCG Holdings position in Q2 2017.
Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2306 holding.
Virtu KCG Holdings first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and has held it in 4 quarters since.
Virtu KCG Holdings's Tetraphase Pharmaceuticals, Inc. position peaked at $276K in Q4 2016.
90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.